Aberrant peripheral blood CD4+ CD25+ FOXP3+ regulatory T cells/T helper-17 number is associated with the outcome of patients with lymphoma

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.

(2018) Marie de Charette et al.   HAEMATOLOGICA

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy.

(2018) Marie de Charette et al.   HAEMATOLOGICA

Microenvironment Cell Contribution to Lymphoma Immunity

(2018) Deepika Kumar et al.   Frontiers in Oncology

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies

(2017) Giovanni D’Arena et al.   Journal of Immunology Research

Human regulatory T cells suppress proliferation of B lymphoma cells

(2016) Monika Anna Grygorowicz et al.   LEUKEMIA & LYMPHOMA

Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma

(2016) Ting Lu et al.   PLoS One

High Levels of Regulatory T Cells in Blood Are a Poor Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma

(2015) Chen Chang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Signs, Symptoms and Complications of Non-Hodgkin's Lymphoma According to Grade and Stage in South Iran

(2015) Mehdi Dehghani et al.   Asian Pacific Journal of Cancer Prevention

Peripheral blood regulatory T cell levels are correlated with some poor prognostic markers in newly diagnosed lymphoma patients

(2015) Eren Gunduz et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma

(2013) Magdalena Głowala-Kosińska et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Non-Hodgkin lymphoma

(2012) Kate R Shankland et al.   LANCET

Prognostic significance of T cell subsets in peripheral blood of B cell non-Hodgkin’s lymphoma patients

(2012) Mehdi Dehghani et al.   MEDICAL ONCOLOGY

The imbalance of Th17/Treg in patients with uterine cervical cancer

(2011) Yan Zhang et al.   CLINICA CHIMICA ACTA

Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro

(2011) Camilla A. Lindqvist et al.   IMMUNOLOGY

T regulatory cells in B-cell malignancy - tumour support or kiss of death?

(2011) Camilla A. Lindqvist et al.   IMMUNOLOGY

The Four types of Tregs in malignant lymphomas

(2011) Jing Wang et al.   Journal of Hematology & Oncology

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

(2009) I. Kryczek et al.   BLOOD

High Numbers of Tumor-Infiltrating Programmed Cell Death 1–Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma

(2009) Joaquim Carreras et al.   JOURNAL OF CLINICAL ONCOLOGY

Phenotypic Analysis of Prostate-Infiltrating Lymphocytes Reveals TH17 and Treg Skewing

(2008) K. S. Sfanos et al.   CLINICAL CANCER RESEARCH

Regulatory T cells as therapeutic target in Hodgkin's lymphoma

(2008) Christian Koenecke et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

(2008) A. Tzankov et al.   HAEMATOLOGICA

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

(2008) Na-Ri Lee et al.   LEUKEMIA & LYMPHOMA